Proteomics-a blessing or a curse? application of proteomics technology to transplant medicine

Katrin Kienzl-Wagner, Johann Pratschke, Gerald Brandacher

Research output: Contribution to journalArticle

Abstract

Proteomics has emerged as a powerful tool in clinical biomarker research. In the field of transplantation, proteomics aims not only at developing noninvasive tools for immune monitoring and identifying biomarkers of allograft rejection but also to gain mechanistic insights into the pathophysiology of an alloimmune response and hence defining new therapeutic targets. A basic knowledge of proteomic technology is a prerequisite to appreciate the complex data generated and required for critical evaluation/interpretation of proteomic-driven studies. This review provides an overview of proteomic approaches and its underlying concepts and discusses the advantages, clinical implications, challenges, and limitations of this exciting modality in transplantation.

Original languageEnglish (US)
Pages (from-to)499-509
Number of pages11
JournalTransplantation
Volume92
Issue number5
DOIs
StatePublished - Sep 15 2011

Fingerprint

Proteomics
Medicine
Technology
Transplants
Transplantation
Biomarkers
Immunologic Monitoring
Allografts
Research
Therapeutics

Keywords

  • Biomarker
  • Proteomics
  • Transplantation

ASJC Scopus subject areas

  • Transplantation

Cite this

Proteomics-a blessing or a curse? application of proteomics technology to transplant medicine. / Kienzl-Wagner, Katrin; Pratschke, Johann; Brandacher, Gerald.

In: Transplantation, Vol. 92, No. 5, 15.09.2011, p. 499-509.

Research output: Contribution to journalArticle

Kienzl-Wagner, Katrin ; Pratschke, Johann ; Brandacher, Gerald. / Proteomics-a blessing or a curse? application of proteomics technology to transplant medicine. In: Transplantation. 2011 ; Vol. 92, No. 5. pp. 499-509.
@article{3d99c478655947868873690660d92f00,
title = "Proteomics-a blessing or a curse? application of proteomics technology to transplant medicine",
abstract = "Proteomics has emerged as a powerful tool in clinical biomarker research. In the field of transplantation, proteomics aims not only at developing noninvasive tools for immune monitoring and identifying biomarkers of allograft rejection but also to gain mechanistic insights into the pathophysiology of an alloimmune response and hence defining new therapeutic targets. A basic knowledge of proteomic technology is a prerequisite to appreciate the complex data generated and required for critical evaluation/interpretation of proteomic-driven studies. This review provides an overview of proteomic approaches and its underlying concepts and discusses the advantages, clinical implications, challenges, and limitations of this exciting modality in transplantation.",
keywords = "Biomarker, Proteomics, Transplantation",
author = "Katrin Kienzl-Wagner and Johann Pratschke and Gerald Brandacher",
year = "2011",
month = "9",
day = "15",
doi = "10.1097/TP.0b013e3182265358",
language = "English (US)",
volume = "92",
pages = "499--509",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Proteomics-a blessing or a curse? application of proteomics technology to transplant medicine

AU - Kienzl-Wagner, Katrin

AU - Pratschke, Johann

AU - Brandacher, Gerald

PY - 2011/9/15

Y1 - 2011/9/15

N2 - Proteomics has emerged as a powerful tool in clinical biomarker research. In the field of transplantation, proteomics aims not only at developing noninvasive tools for immune monitoring and identifying biomarkers of allograft rejection but also to gain mechanistic insights into the pathophysiology of an alloimmune response and hence defining new therapeutic targets. A basic knowledge of proteomic technology is a prerequisite to appreciate the complex data generated and required for critical evaluation/interpretation of proteomic-driven studies. This review provides an overview of proteomic approaches and its underlying concepts and discusses the advantages, clinical implications, challenges, and limitations of this exciting modality in transplantation.

AB - Proteomics has emerged as a powerful tool in clinical biomarker research. In the field of transplantation, proteomics aims not only at developing noninvasive tools for immune monitoring and identifying biomarkers of allograft rejection but also to gain mechanistic insights into the pathophysiology of an alloimmune response and hence defining new therapeutic targets. A basic knowledge of proteomic technology is a prerequisite to appreciate the complex data generated and required for critical evaluation/interpretation of proteomic-driven studies. This review provides an overview of proteomic approaches and its underlying concepts and discusses the advantages, clinical implications, challenges, and limitations of this exciting modality in transplantation.

KW - Biomarker

KW - Proteomics

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=80052394590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052394590&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e3182265358

DO - 10.1097/TP.0b013e3182265358

M3 - Article

C2 - 21716169

AN - SCOPUS:80052394590

VL - 92

SP - 499

EP - 509

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 5

ER -